Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Bayer patent describes therapeutic agents for urinary incontinence

May 10, 2006

Phase IIb studies of bremelanotide in erectile dysfunction complete enrollment

May 8, 2006

Ilypsa grants Astellas Japanese rights to ILY-101

May 2, 2006

Safetek to develop new selective muscarinic receptor antagonist for OAB

April 28, 2006

Vaprisol launched for treatment of euvolemic hyponatremia

April 27, 2006

hMaxi-K gene transfer for erectile dysfunction safe in phase I study

April 27, 2006

SUNRISE study reveals urinary urgency improvement with solifenacin

April 27, 2006

Tolterodine improves overactive bladder symptoms and patient quality of life

April 27, 2006

Pfizer announces new tolterodine study and releases data on overactive bladder prevalence

April 26, 2006

Urinary incontinence improved by cizolirtine in overactive bladder patients

April 26, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...